290 related articles for article (PubMed ID: 16509930)
1. Inflammation in end-stage renal disease: the hidden enemy.
Stenvinkel P
Nephrology (Carlton); 2006 Feb; 11(1):36-41. PubMed ID: 16509930
[TBL] [Abstract][Full Text] [Related]
2. New insights on inflammation in chronic kidney disease-genetic and non-genetic factors.
Stenvinkel P
Nephrol Ther; 2006 Jul; 2(3):111-9. PubMed ID: 16890135
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein in end-stage renal disease: are there reasons to measure it?
Stenvinkel P; Lindholm B
Blood Purif; 2005; 23(1):72-8. PubMed ID: 15627740
[TBL] [Abstract][Full Text] [Related]
4. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
[TBL] [Abstract][Full Text] [Related]
5. Inflammation in end-stage renal disease--a fire that burns within.
Stenvinkel P
Contrib Nephrol; 2005; 149():185-199. PubMed ID: 15876843
[TBL] [Abstract][Full Text] [Related]
6. Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease.
Yao Q; Pecoits-Filho R; Lindholm B; Stenvinkel P
Scand J Urol Nephrol; 2004; 38(5):405-16. PubMed ID: 15764253
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of C-reactive protein for heart disease in dialysis patients.
Wang AY
Curr Opin Investig Drugs; 2005 Sep; 6(9):879-86. PubMed ID: 16187687
[TBL] [Abstract][Full Text] [Related]
8. Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus.
Suliman ME; Stenvinkel P; Bárány P; Heimbürger O; Anderstam B; Lindholm B
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S89-95. PubMed ID: 12612961
[TBL] [Abstract][Full Text] [Related]
9. Causes and consequences of inflammation on anemia management in hemodialysis patients.
Chawla LS; Krishnan M
Hemodial Int; 2009 Apr; 13(2):222-34. PubMed ID: 19432697
[TBL] [Abstract][Full Text] [Related]
10. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
[TBL] [Abstract][Full Text] [Related]
11. Interactions between inflammation, oxidative stress, and endothelial dysfunction in end-stage renal disease.
Stenvinkel P
J Ren Nutr; 2003 Apr; 13(2):144-8. PubMed ID: 12671839
[TBL] [Abstract][Full Text] [Related]
12. Inflammation in ESRD: causes and potential consequences.
Kaysen GA; Kumar V
J Ren Nutr; 2003 Apr; 13(2):158-60. PubMed ID: 12671842
[TBL] [Abstract][Full Text] [Related]
13. [Chronic inflammation and cardiovascular risk in hemodialysis].
Pertosa G; Simone S; Soccio M; Marrone D; Grandaliano G
G Ital Nefrol; 2003; 20(6):631-40. PubMed ID: 14732917
[TBL] [Abstract][Full Text] [Related]
14. Excellent agreement between C-reactive protein measurement methods in end-stage renal disease patients--no additional power for mortality prediction with high-sensitivity CRP.
Grootendorst DC; de Jager DJ; Brandenburg VM; Boeschoten EW; Krediet RT; Dekker FW;
Nephrol Dial Transplant; 2007 Nov; 22(11):3277-84. PubMed ID: 17623721
[TBL] [Abstract][Full Text] [Related]
15. IL-18 is involved in vascular injury in end-stage renal disease patients.
Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
[TBL] [Abstract][Full Text] [Related]
16. Endothelial function, CRP and oxidative stress in chronic kidney disease.
Annuk M; Soveri I; Zilmer M; Lind L; Hulthe J; Fellström B
J Nephrol; 2005; 18(6):721-6. PubMed ID: 16358230
[TBL] [Abstract][Full Text] [Related]
17. Predictors of cardiovascular death in ESRD.
Zoccali C; Tripepi G; Mallamaci F
Semin Nephrol; 2005 Nov; 25(6):358-62. PubMed ID: 16298255
[TBL] [Abstract][Full Text] [Related]
18. Inflammation but not oxidative stress is associated with beta-chemokine levels and prevalence of cardiovascular disease in uraemic patients.
Pawlak K; Pawlak D; Myśliwiec M
Cytokine; 2006 Sep; 35(5-6):258-62. PubMed ID: 17070067
[TBL] [Abstract][Full Text] [Related]
19. [Chronic inflammation, oxidative stress and effects of erythropoetin in end-stage renal disease patients].
Lazarević T; Stojimirović B; Poskurica M; Lazarević M; Mitrović N; Stolić R
Med Pregl; 2007; 60 Suppl 2():109-13. PubMed ID: 18928173
[TBL] [Abstract][Full Text] [Related]
20. Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease.
Carrero JJ; Qureshi AR; Axelsson J; Yilmaz MI; Rehnmark S; Witt MR; Bárány P; Heimbürger O; Suliman ME; Alvestrand A; Lindholm B; Stenvinkel P
J Intern Med; 2007 Dec; 262(6):690-701. PubMed ID: 17908160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
